The United States Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the T-Detect COVID Test developed by Adaptive Biotechnologies. FDA notes that the T-Detect COVID Test is a next generation sequencing based test to aid in identifying individuals with an adaptive T cell immune response to COVID-19, indicating recent or prior infection with COVID-19. To read the FDA announcement and summary of the issuance of an EUA for the T-Detect COVID Test, use the link below.
https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-adaptive-biotechnologies-t-detect-covid-test?utm_medium=email&utm_source=govdelivery